{Reference Type}: Journal Article {Title}: Characteristics, demographics, and epidemiology of possible chronic cough in Sweden: A nationwide register-based cohort study. {Author}: Walz L;Illergård K;Arpegård J;Dorbesi C;Johansson H;Ingi Emilsson Ö; {Journal}: PLoS One {Volume}: 19 {Issue}: 7 {Year}: 2024 {Factor}: 3.752 {DOI}: 10.1371/journal.pone.0303804 {Abstract}: OBJECTIVE: To show clinical characteristics, treatments, and comorbidities in chronic cough in a nationwide cohort.
METHODS: Two cohorts were created. A national cohort with individuals from two population-based databases; the National Patient Register and Swedish Prescribed Drug Register. Secondly, a regional cohort including primary care data. Adults with at least one cough diagnosis (ICD-10 R05) and/or individuals with ≥2 dispensed prescriptions for relevant cough-medication within the inclusion period, 2016-2018, were identified. Individuals on medications which may instigate cough or suggest acute infection or diagnosed with conditions where cough is a cardinal symptom, were excluded. Those remaining were defined as having possible refractory or unexplained chronic cough (RCC/UCC).
RESULTS: Altogether 62,963 individuals were identified with possible RCC/UCC, giving a national prevalence of about 1%. Mean age was 56 years and 60% were females. Many (44%) of the individuals with possible RCC/UCC visited cough relevant specialist clinics during the study period, but less than 20% received a cough diagnosis. A majority (63%) had evidence of RCC/UCC in the 10 years prior to inclusion in the study. In the regional cohort, including primary care data, the prevalence of RCC/UCC was doubled (2%). Cough medicines were mainly prescribed by primary care physicians (82%).
CONCLUSIONS: Most individuals with possible RCC/UCC sought medical care in primary care, and had a long history of cough, with various treatments tried, indicating a substantial burden of the condition. Referrals to specialist care were very rare. The results underline the need for a structured multidisciplinary approach and future therapeutic options.